82 related articles for article (PubMed ID: 3592111)
1. [Comparative research on different treatment regimens in disseminated cancer of the ovaries].
Marinov L; Koĭnov K; Tsekova V; Velikova M
Akush Ginekol (Sofiia); 1987; 26(1):49-52. PubMed ID: 3592111
[No Abstract] [Full Text] [Related]
2. [The potentials of combined chemotherapy in disseminated ovarian cancer].
Gorbunova VA; Perevodchikova NI; Kozachenko VP; Ryzhakov VM; Marenich AF; Zhordania KI
Akush Ginekol (Mosk); 1991 Feb; (2):54-7. PubMed ID: 1907433
[No Abstract] [Full Text] [Related]
3. Six-drug chemotherapy (hexamethylmelamine, doxorubicin, cisplatin, cyclophosphamide, methotrexate, and 5-FU; CHAMP-5) for ovarian carcinoma: alternating sequences of combination regimens.
Pasmantier MW; Coleman M; Silver RT; Ballard WP
Cancer Treat Rep; 1985 Jun; 69(6):689-93. PubMed ID: 3926310
[TBL] [Abstract][Full Text] [Related]
4. [Combined chemotherapy including platinum derivatives in the combined treatment of patients with stage-III to -IV ovarian cancer].
Perevodchikova NI; Gorbunova VA; Grigorova TM; Kozachenko VP; Marenich AF
Vestn Akad Med Nauk SSSR; 1986; (5):8-11. PubMed ID: 3755271
[No Abstract] [Full Text] [Related]
5. [An evaluation of two postoperative chemotherapy protocols in ovarian common epithelial cancer: a comparison of continuous and intermittent hospitalization].
Sakamoto H; Suzuki H; Hayakawa S; Kiseki Y; Miyakawa Y; Ohkubo Y; Watanabe Y; Takami M; Kashiwazaki K; Tanaka H
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1491-4. PubMed ID: 2584826
[No Abstract] [Full Text] [Related]
6. [Use of metoclopramide and dexamethasone in preventing vomiting associated with antineoplastic chemotherapy].
Sobkowski W; Jassem J
Pol Tyg Lek; 1987 Jul 6-7; 42(27-28):841-3. PubMed ID: 3684761
[No Abstract] [Full Text] [Related]
7. Chemotherapy for stage III-IV epithelial ovarian cancer with cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide: a preliminary report.
Ehrlich CE; Einhorn L; Williams SD; Morgan J
Cancer Treat Rep; 1979 Feb; 63(2):281-8. PubMed ID: 376134
[No Abstract] [Full Text] [Related]
8. ICON 2 and ICON 3 data in previously untreated ovarian cancer: results to date.
Harper P
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-23-S15-25. PubMed ID: 9346217
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of advanced ovarian carcinoma with cyclophosphamide, adriamycin and cisplatin: evaluation of the therapeutic response and analysis of the collateral effects].
Facchini V; Gadducci A; Ceccarelli P; Dell'Arciprete T; Del Bravo B; Bartolini T; Fioretti P
Ann Ostet Ginecol Med Perinat; 1986; 107(6):359-68. PubMed ID: 3566043
[No Abstract] [Full Text] [Related]
10. Hexamethylmelamine-CAF (cyclophosphamide, methotrexate, and 5-FU) and cisplatin-CAF in refractory ovarian cancer.
Sessa C; D'Incalci M; Valente I; Bolis G; Colombo N; Mangioni C
Cancer Treat Rep; 1982 May; 66(5):1233-4. PubMed ID: 6805951
[No Abstract] [Full Text] [Related]
11. A review of 28 years of treating advanced ovarian cancer.
Krommer CF; Szalai JP
Anticancer Res; 1993; 13(3):817-25. PubMed ID: 8317918
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin, doxorubicin, and cyclophosphamide (PAC) in the treatment of mixed mesodermal tumor of the ovary.
Wheelock J; Hancock K; Smith K
Cancer Treat Rep; 1987 Dec; 71(12):1275-6. PubMed ID: 3690537
[No Abstract] [Full Text] [Related]
13. Options for primary chemotherapy in advanced ovarian cancer: the European perspective.
Colombo N; Maggioni A; Vignali M; Parma G; Mangioni C
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S108-13. PubMed ID: 7835793
[TBL] [Abstract][Full Text] [Related]
14. Re: Mucinous ovarian cancer.
Omura GA
Gynecol Oncol; 2005 Dec; 99(3):789; author reply 789-90. PubMed ID: 16125757
[No Abstract] [Full Text] [Related]
15. [Chemotherapeutic treatment of advanced ovarian carcinoma. Preliminary results of the Piedmont-Liguria Cooperative Group].
Conte PF; Rosso R; Bruzzone M; Sertoli MR; Rubagotti A; Santi L; Carnino F; Cottini M; Mossetti C; Gatti M
Minerva Ginecol; 1984 Apr; 36(4):213-6. PubMed ID: 6547773
[No Abstract] [Full Text] [Related]
16. High-dose chemotherapy with autologous bone marrow transplantation for the treatment of malignant ovarian tumors.
Murakami M; Shinozuka T; Kuroshima Y; Tokuda Y; Tajima T
Semin Oncol; 1994 Feb; 21(1 Suppl 1):29-32. PubMed ID: 8153654
[No Abstract] [Full Text] [Related]
17. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.
Thigpen T; Vance R; Puneky L; Khansur T
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816
[TBL] [Abstract][Full Text] [Related]
18. Cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin (CHAD) as second-line chemotherapy for ovarian adenocarcinoma.
Piver MS; Lele S; Barlow JJ
Cancer Treat Rep; 1981; 65(1-2):149-51. PubMed ID: 6784921
[TBL] [Abstract][Full Text] [Related]
19. [Chemotherapy of ovarian tumors using cis-platin].
Laurová L; Kobilková J; Novotná J; Motlík K; Fricová M; Hornický J
Cesk Gynekol; 1987 Feb; 52(1):41-4. PubMed ID: 3568161
[No Abstract] [Full Text] [Related]
20. [Chemotherapy of epithelial ovarian carcinoma].
Bruntsch U; Gallmeier WM
MMW Munch Med Wochenschr; 1983 Nov; 125(44):993-5. PubMed ID: 6417517
[No Abstract] [Full Text] [Related]
[Next] [New Search]